Atlas Trials

Moderate to Severe Acute Respiratory Distress Syndrome Associated With COVID-19

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Moderate to Severe Acute Respiratory Distress Syndrome Associated With COVID-19

RecordFirmDate
Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19 Infection (NCT04366830)Mesoblast International Sàrl

Track Moderate to Severe Acute Respiratory Distress Syndrome Associated With COVID-19 automatically

Every clearance here is in the API, with alerts when new ones post.